Evidence map›Paper›PMID 29881232›Full record

ReviewWorld journal of gastroenterology2018

Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.

Niranga Manjuri Devanarayana, Shaman Rajindrajith

3 registry-linked trialsAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05719246 narecruitingnot on this mapstarted 2020, after this paper: background citation

Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome

TypeinterventionalSponsorThe Cooper Health SystemRan2020 to 2026Enrolled10ConditionsIrritable Bowel Syndrome, Anxiety, Quality of LifeArmsYoga
NCT05738343 unknown statusnot on this mapstarted 2023, after this paper: background citation

Adesione Alla Dieta Mediterranea Dei Pazienti Pediatrici Affetti Dalla Sindrome Dell'Intestino Irritabile (IBS): Studio Pilota

TypeobservationalSponsorUniversity of Roma La SapienzaRan2023 to 2024Enrolled50ConditionsIrritable Bowel SyndromeArmsdieta mediterranea
NCT06268964 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Comparative Effect of Trimebutine and Probiotics on Functional Abdominal Pain Disorders (FAPD) in Children: Randomized Clinical Trial (RCT)

TypeinterventionalSponsorUniversidad de ColimaRan2024 to 2025Enrolled82ConditionsFunctional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders, Irritable Bowel Syndrome Variant of ChildhoodArmsTrimebutine, Lactobacillus rhamnosus, Placebo
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Nutraceuticals and biotics in pediatric gastrointestinal disorders.European journal of clinical nutrition · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Niranga Manjuri DevanarayanaDepartment of Physiology, Faculty of Medicine, University of Kelaniya, Ragama 11010, Sri Lanka. niranga@kln.ac.lk.
Shaman RajindrajithDepartment of Paediatrics, Faculty of Medicine, University of Kelaniya, Ragama 11010, Sri Lanka.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a common and troublesome disorder in children with an increasing prevalence noted during the past two decades. It has a significant effect on the lives of affected children and their families and poses a significant burden on healthcare systems. Standard symptom-based criteria for diagnosis of pediatric IBS have changed several times during the past two decades and there are some differences in interpreting symptoms between different cultures. This has posed a problem when using them to diagnose IBS in clinical practice. A number of potential patho-physiological mechanisms have been described, but so far the exact underlying etiology of IBS is unclear. A few potential therapeutic modalities have been tested in children and only a small number of them have shown some benefit. In addition, most of the described patho-physiological mechanisms and treatment options are based on adult studies. These have surfaced as challenges when dealing with pediatric IBS and they need to be overcome for effective management of children with IBS. Recently suggested top-down and bottom-up models help integrating reported patho-physiological mechanisms and will provide an opportunity for better understanding of the diseases process. Treatment trials targeting single treatment modalities are unlikely to have clinically meaningful therapeutic effects on IBS with multiple integrating patho-physiologies. Trials focusing on multiple combined pharmacological and non-pharmacological therapies are likely to yield more benefit. In addition to treatment, in the future, attention should be paid for possible prevention strategies for IBS.

Indexed as

ChildCombined Modality TherapyGastrointestinal AgentsGastrointestinal MicrobiomeGastrointestinal MotilityHumansIntestinal MucosaIrritable Bowel SyndromeMind-Body TherapiesModels, BiologicalPrevalenceTreatment OutcomeGastrointestinal AgentsAbdominal painFunctional gastrointestinal disorderIrritable bowel syndromeManagementMicrobiotaPatho-physiologyPost-infectious

Identifiers

PMID29881232
PMCPMC5989237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.